Pathobiology
K |
|||
(33 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
Zeile 1: | Zeile 1: | ||
{{pnc}} | {{pnc}} | ||
− | + | {{ft|I}} | |
+ | *[https://www.webmd.com/lung/news/20200522/blood-vessels-in-lungs-split-in-response-to-covid19 special pattern of pulmonary neoagiogenesis] | ||
+ | *[https://www.youtube.com/watch?v=y6h8TIxeg1g doctors youtube on autopsy findings 05/2020] | ||
+ | {{tp|p=32273135|t=ä. Analysis of Characteristics in Death Patients with COVID-19 Pneumonia without Underlying Diseases |pdf=|usr=}} | ||
+ | {{tp|p=32275742|t=ä. COVID-19 Autopsies, Oklahoma, USA |pdf=|usr=}} | ||
+ | {{tp|p=32361635|t=2020. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients |pdf=|usr=}} | ||
+ | {{tp|p=32163542|t=ä. Histopathologic Changes and SARS?CoV-2 Immunostaining in the Lung of a Patient With COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32360606|t=2020. SARS-CoV2 entry and spread in the lymphatic drainage system of the brain |pdf=|usr=}} | ||
+ | {{tp|p=32353523|t=ä. SARS-CoV-2: a new virus but a familiar inflammation brain pattern |pdf=|usr=}} | ||
+ | {{tp|p=32370257|t=2020. Bioenergy Crisis in Coronavirus Diseases?|pdf=|usr=}} | ||
+ | {{tp|p=32375085|t=ä. Pathophysiological Characteristics and Therapeutic Approaches for Pulmonary Injury and Cardiovascular Complications of Coronavirus Disease 2019 |pdf=|usr=}} | ||
+ | {{tp|p=32346074|t=ä. Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient |pdf=|usr=}} | ||
+ | {{tp|p=32360729|t=ä. Postmortem Lung Findings in an Asthmatic with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32283063|t=ä. A call to action : the need for autopsies to determine the full extent of organ involvement associated with COVID-19 infections |pdf=|usr=}} | ||
{{tp|p=32334082|t=ä. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection |pdf=|usr=}} | {{tp|p=32334082|t=ä. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection |pdf=|usr=}} | ||
{{tp|p=32270184|t=ä. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 |pdf=|usr=}} | {{tp|p=32270184|t=ä. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 |pdf=|usr=}} | ||
{{tp|p=32307550|t=ä. Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients |pdf=|usr=}} | {{tp|p=32307550|t=ä. Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients |pdf=|usr=}} | ||
− | + | {{tp|p=32207983|t=2020. Covid-19 infection and mortality: a physiologist?s perspective enlightening clinical features and plausible interventional strategies |pdf=|usr=}} | |
{{tp|p=32234451|t=ä. COVID-19, SARS and MERS: are they closely related?|pdf=|usr=}} | {{tp|p=32234451|t=ä. COVID-19, SARS and MERS: are they closely related?|pdf=|usr=}} | ||
+ | {{tp|p=32575076|t=2020. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.|pdf=|usr=010}} | ||
+ | {{tp|p=32294179|t=ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications |pdf=|usr=}} | ||
+ | {{tp|p=32293672|t=ä. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts |pdf=|usr=}} | ||
+ | {{tp|p=32350105|t=ä. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection |pdf=|usr=}} | ||
+ | {{tp|p=32341103|t=2020. Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review |pdf=|usr=}} | ||
+ | {{tp|p=32198987|t=2020. Gross examination report of a COVID-19 death autopsy |pdf=|usr=}} | ||
+ | {{tp|p=32198986|t=2020. Review and Prospect of Pathological Features of Corona Virus Disease |pdf=|usr=}} | ||
+ | {{tp|p=32198985|t=2020. Guide to the Forensic Pathology Practice on Death Cases Related to Corona Virus Disease 2019 COVID-19 Trial Draft |pdf=|usr=}} | ||
+ | {{tp|p=32198984|t=2020. Academician Cong Bin: Autopsy of SARS-CoV-2 infection is needed to be strengthened |pdf=|usr=}} | ||
+ | {{tp|p=32198983|t=2020. From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy |pdf=|usr=}} | ||
+ | {{tp|p=32170560|t=ä. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection |pdf=|usr=}} | ||
+ | {{tp|p=32551862|t=2020. NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19.|pdf=|usr=010}} | ||
+ | {{tp|p=32317509|t=2020. COVID-19 and lung pathology |pdf=|usr=}} | ||
+ | {{tp|p=32345362|t=2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues |pdf=|usr=}} | ||
+ | {{tp|p=32333601|t=ä. Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD |pdf=|usr=}} | ||
+ | {{tp|p=32586680|t=2020. A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients.|pdf=|usr=010}} | ||
+ | {{tp|p=32094336|t=2020. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa |pdf=|usr=}} | ||
+ | {{tp|p=32283245|t=ä. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated |pdf=|usr=}} | ||
+ | {{tp|p=32282428|t=ä. What s Old is New! Similarities Between SARS-CoV-2 and HIV |pdf=|usr=}} | ||
+ | {{tp|p=32303424|t=ä. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32315733|t=ä. Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms |pdf=|usr=}} | ||
+ | {{ttp|p=32583086|t=2020. COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure.|pdf=|usr=010}} | ||
+ | {{tp|p=32357503|t=2020. COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!|pdf=|usr=}} | ||
+ | {{tp|p=32244779|t=2020. Master Regulator Analysis of the SARS-CoV-2/Human Interactome |pdf=|usr=}} | ||
+ | {{tp|p=32366599|t=2020. SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma |pdf=|usr=}} | ||
+ | {{tp|p=32565512|t=2020. Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China.|pdf=|usr=010}} | ||
+ | {{tp|p=32283163|t=ä. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32348495|t=ä. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32344401|t=2020. COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes |pdf=|usr=}} | ||
+ | {{tp|p=32080991|t=2020. Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea |pdf=|usr=}} | ||
+ | {{tp|p=32056249|t=2020. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS?CoV, MERS?CoV, and 2019?nCoV |pdf=|usr=}} | ||
+ | {{tp|p=32539769|t=2020. COVID-19 targets the right lung.|pdf=|usr=010}} | ||
+ | {{tp|p=32340678|t=2020. Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process |pdf=|usr=}} | ||
+ | {{tp|p=32194247|t=ä. Exuberant Plasmocytosis in Bronchoalveolar Lavage Specimen of the First Patient Requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe |pdf=|usr=}} | ||
+ | {{tp|p=32114094|t=ä. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer |pdf=|usr=}} | ||
+ | {{tp|p=32558055|t=2020. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection.|pdf=|usr=010}} | ||
+ | {{tp|p=32379723|t=2020. Molecular detection of SARS-CoV-2 in formalin fixed paraffin embedded specimens |pdf=|usr=}} | ||
+ | {{ttp|p=32329756|t=2020. Neutrophil extracellular traps in COVID-19 |pdf=|usr=}} | ||
+ | {{ttp|p=32574956|t=2020. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.|pdf=|usr=010}} | ||
+ | {{tp|p=32368701|t=ä. COVID-19?Associated Collapsing Glomerulopathy: An Emerging Entity |pdf=|usr=}} | ||
+ | {{tp|p=32327202|t=ä. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China |pdf=|usr=}} | ||
+ | {{tp|p=C7142700|t=ä. Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}} | ||
+ | {{tp|p=32346659|t=ä. Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection |pdf=|usr=}} | ||
+ | {{tp|p=32311318|t=ä. SARS-CoV-2 and viral sepsis: observations and hypotheses |pdf=|usr=}} | ||
+ | {{tp|p=32325026|t=2020. Endothelial cell infection and endotheliitis in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32559338|t=2020. Autopsy registry can facilitate COVID-19 research.|pdf=|usr=010}} | ||
+ | {{tp|p=32199493|t=ä. Viral dynamics in mild and severe cases of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32330440|t=ä. Mediastinal lymphadenopathy in patients with severe COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32105638|t=ä. Viral load of SARS-CoV-2 in clinical samples |pdf=|usr=}} | ||
+ | {{tp|p=32085846|t=ä. Pathological findings of COVID-19 associated with acute respiratory distress syndrome |pdf=|usr=}} | ||
+ | {{tp|p=32341791|t=2020. Thoughts on COVID-19 and autoimmune diseases |pdf=|usr=}} | ||
+ | {{tp|p=32344305|t=ä. A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: potential implications for the SARS-CoV-2 modus operandi |pdf=|usr=}} | ||
+ | {{tp|p=32583353|t=2020. What about COVID-19 and arachidonic acid pathway?|pdf=|usr=010}} | ||
+ | {{tp|p=32243911|t=ä. C-reactive protein levels in the early stage of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32291399|t=ä. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies |pdf=|usr=}} | ||
+ | {{tp|p=32249846|t=ä. Dysregulation of lung myeloid cells in COVID-19 |pdf=|usr=}} | ||
+ | {{ttp|p=32554538|t=2020. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?|pdf=|usr=010}} | ||
+ | {{tp|p=32216698|t=2020. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility |pdf=|usr=}} | ||
+ | {{tp|p=32297540|t=2020. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study |pdf=|usr=}} | ||
+ | {{tp|p=32348339|t=2020. Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control study |pdf=|usr=}} | ||
+ | {{tp|p=32298273|t=2020. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study |pdf=|usr=}} | ||
+ | {{tp|p=32542743|t=2020. Diffuse Alveolar Damage (DAD) from Coronavirus Disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.|pdf=|usr=010}} | ||
+ | {{tp|p=32326988|t=ä. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study }} | ||
+ | {{tp|p=32339247|t=ä. Does apolipoprotein E genotype predict COVID-19 severity?|pdf=|usr=}} | ||
+ | {{tp|p=32371949|t=2020. Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study |pdf=|usr=}} | ||
+ | {{ttp|p=32360977|t=ä. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?|pdf=|usr=}} | ||
+ | {{ttp|p=32305740|t=ä. Severe COVID-19 infection associated with endothelial activation |pdf=|usr=}} | ||
+ | {{ttp|p=32299776|t=ä. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases |pdf=|usr=}} | ||
+ | {{tp|p=32283217|t=ä. Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings |pdf=|usr=}} | ||
+ | {{tp|p=32356025|t=ä. Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen |pdf=|usr=}} | ||
+ | {{tp|p=32350596|t=ä. The autopsy debate during the COVID-19 emergency: the Italian experience |pdf=|usr=}} | ||
+ | {{tp|p=32552178|t=2020. Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients.|pdf=|usr=010}} | ||
+ | {{tp|p=32379417|t=ä. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age |pdf=|usr=}} | ||
+ | {{ttp|p=32376402|t=ä. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies |pdf=|usr=}} | ||
+ | {{ttp|p=32361194|t=ä. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons |pdf=|usr=}} | ||
+ | {{ttp|p=32323565|t=2020. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19?|pdf=|usr=}} | ||
+ | {{tp|p=32379894|t=2020. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32259373|t=2020. Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An Italian institutional experience focusing on biosafety procedures |pdf=|usr=}} | ||
+ | {{tp|p=32346073|t=2020. COVID-19: towards understanding of pathogenesis |pdf=|usr=}} | ||
+ | {{ttp|p=32557383|t=2020. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients.|pdf=|usr=010}} | ||
+ | {{tp|p=32294809|t=2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |pdf=|usr=}} | ||
+ | {{tp|p=32246845|t=2020. SARS?CoV?2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells |pdf=|usr=}} | ||
+ | {{tp|p=32353898|t=2020. Histopathology and genetic susceptibility in COVID-19 pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32367579|t=2020. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications |pdf=|usr=}} | ||
+ | {{tp|p=32559180|t=2020. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.|pdf=|usr=010}} | ||
+ | {{tp|p=32364407|t=2020. COVID-19 Lung Injury Is Different From High Altitude Pulmonary Edema (Re: High Alt Med Biol Epub ahead of print ; DOI: 10 1089/ham 2020 0055) |pdf=|usr=}} | ||
+ | {{tp|p=32281877|t=2020. COVID-19 Lung Injury is Not High Altitude Pulmonary Edema |pdf=|usr=}} | ||
+ | {{tp|p=32374419|t=2020. Pulmonary Pathology of Early Phase COVID-19 Pneumonia in a Patient with a Benign Lung Lesion |pdf=|usr=}} | ||
+ | {{ttp|p=32364264|t=2020. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction |pdf=|usr=}} | ||
+ | {{ttp|p=32371536|t=2020. Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32198191|t=2020. Autopsy in suspected COVID-19 cases |pdf=|usr=}} | ||
+ | {{tp|p=32358895|t=2020. Histological pattern in Covid-19 induced viral rash |pdf=|usr=}} | ||
+ | {{tp|p=32554923|t=2020. The complement system in COVID-19: friend and foe?|pdf=|usr=010}} | ||
+ | {{tp|p=32369204|t=2020. Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications |pdf=|usr=}} | ||
+ | {{tp|p=32294295|t=2020. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 |pdf=|usr=}} | ||
+ | {{ttp|p=32376101|t=ä. Association Between Hypoxemia and Mortality in Patients With COVID-19 |pdf=|usr=}} | ||
+ | {{ttp|p=32272081|t=2020. Understanding pathways to death in patients with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32327758|t=2020. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes |pdf=|usr=}} | ||
+ | {{tp|p=32572155|t=2020. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.|pdf=|usr=010}} | ||
+ | {{tp|p=32576678|t=2020. Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.|pdf=|usr=010}} | ||
+ | {{tp|p=32592919|t=2020. Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): Gender and age influences.|pdf=|usr=010}} | ||
+ | {{tp|p=32570168|t=2020. Microvascular disease confers additional risk to COVID-19 infection.|pdf=|usr=010}} | ||
+ | {{tp|p=32273618|t=2020. How does COVID-19 kill? Uncertainty is hampering doctors ability to choose treatments |pdf=|usr=}} | ||
+ | {{ttp|p=32371892|t=2020. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms |pdf=|usr=}} | ||
+ | {{tp|p=32339089|t=2020. Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis |pdf=|usr=}} | ||
+ | {{tp|p=32172546|t=2020. A pathological report of three COVID-19 cases by minimal invasive autopsies |pdf=|usr=}} | ||
+ | {{tp|p=32171194|t=2020. Pathological changes with novel coronavirus infection in lung cancer surgical specimen |pdf=|usr=}} | ||
+ | {{tp|p=32153166|t=2020. Provisional guidelines on autopsy practice for deaths associated with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32268662|t=2020. Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy |pdf=|usr=}} | ||
+ | {{tp|p=32157847|t=2020. How to understand the histopathology of SARS and coronavirus disease-19 (COVID-19) associated with acute respiratory distress syndrome |pdf=|usr=}} | ||
+ | {{tp|p=32084674|t=2020. Detection of 2019-nCoV in the pathological paraffin embedded tissue |pdf=|usr=}} | ||
+ | {{tp|p=32340089|t=2020. Pathological changes of the spleen in ten patients with new coronavirus infection by minimally invasive autopsies |pdf=|usr=}} | ||
+ | {{tp|p=32114744|t=2020. Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases |pdf=|usr=}} | ||
+ | {{tp|p=32174095|t=2020. Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures |pdf=|usr=}} | ||
+ | {{tp|p=32561849|t=2020. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19.|pdf=|usr=010}} | ||
+ | {{tp|p=C7173822|t=2020. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study |pdf=|usr=}} | ||
+ | {{tp|p=32379077|t=2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS |pdf=|usr=}} | ||
+ | {{tp|p=32434133|t=2020. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities |pdf=|usr=}} | ||
+ | {{ttp|p=32314313|t=ä. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?|pdf=|usr=}} ''After studying the published clinical reports, what surprised me is that most patients who had the most severe complications were affected by two comorbidities (or their long-term effects): hypertension and diabetes. Both of them induce, among other problems, '''chronic stress on endothelial cells''' that in turn can express molecules on their plasma membranes abnormally... ...In turn, these autoimmune reactions against endothelium can generate thrombosis, disseminated intravascular coagulation and multi-organ failure.'' | ||
+ | {{tp|p=32427582|t=2020. Clinical and pathological investigation of severe COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{ttp|p=32512569|t=2020. COVID-19 Attacks the Kidney: Ultrastructural Evidence for the Presence of Virus in the Glomerular Epithelium.|pdf=|usr=007}} | ||
+ | {{ttp|p=32403217|t=2020. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.|pdf=|usr=007}} | ||
+ | {{tp|p=32272221|t=ä. Host proteases as determinants of coronaviral neurotropism and virulence |pdf=|usr=}} | ||
+ | {{ttp|p=32243808|t=2020. The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future |pdf=|usr=}} | ||
+ | {{tp|p=32375845|t=2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?|pdf=|usr=}} | ||
+ | {{tp|p=32439197|t=ä. COVID-19 and Multiorgan Response |pdf=|usr=}} | ||
+ | {{tp|p=32362921|t=2020. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies |pdf=|usr=}} | ||
+ | {{tp|p=32340677|t=2020. Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia |pdf=|usr=}} | ||
+ | {{tp|p=32471641|t=ä. Tubuloreticular inclusions in COVID-19?related collapsing glomerulopathy |pdf=|usr=}} | ||
+ | {{tp|p=32471639|t=ä. Collapsing glomerulopathy in a COVID-19 patient |pdf=|usr=}} | ||
+ | {{tp|p=32292867|t=2020. Collapsing Glomerulopathy in a Patient With COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32459663|t=2020. COVID-19, microangiopathy, hemostatic activation, and complement.|pdf=|usr=007}} | ||
+ | {{tp|p=32242089|t=ä. Endocrine and metabolic link to coronavirus infection |pdf=|usr=}} | ||
+ | {{tp|p=32382135|t=ä. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis |pdf=|usr=}} | ||
+ | {{tp|p=C7158196|t=2009. 64pp on topic review (+) Molecular Basis of Pulmonary Disease |pdf=|usr=}} | ||
+ | {{tp|p=C7197563|t=ä. Plasma Metabolomic and Lipidomic Alterations Associated with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32454497|t=2020. COVID-19 and Nasal Cytobrush Cytology.|pdf=|usr=007}} | ||
+ | {{tp|p=32437316|t=2020. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32412897|t=2020. Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.|pdf=|usr=007}} | ||
+ | {{tp|p=32484232|t=2020. Radiologisk och histologisk bild for en okad forstaelse vid covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32512290|t=2020. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{ttp|p=32401000|t=2020. First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem.|pdf=|usr=007}} | ||
+ | {{tp|p=32397896|t=2020. Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings.|pdf=|usr=007}} | ||
+ | {{ttp|p=32436629|t=2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.|pdf=|usr=007}} | ||
+ | {{ttp|p=32421281|t=2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?|pdf=|usr=007}} | ||
+ | {{tp|p=32485101|t=2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.|pdf=|usr=007}} | ||
+ | {{tp|p=32423917|t=2020. COVID-19 as an Acute Inflammatory Disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32469258|t=2020. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.|pdf=|usr=007}} | ||
+ | {{ttp|p=32437597|t=2020. Covid-19, Angiogenesis, and ARDS Endotypes.|pdf=|usr=007}} | ||
+ | {{ttp|p=32437596|t=2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32213267|t=2020. [Interpretation of pathological changes for "Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Version 7) "].|pdf=|usr=007}} | ||
+ | {{ttp|p=32490726|t=2020. Thromboinflammatory response in SARS-CoV-2 sepsis.|pdf=|usr=007}} | ||
+ | {{ttp|p=32348061|t=2020. COVID-19, une maladie endotheliale ?|pdf=|usr=007}} | ||
+ | {{tp|p=32455515|t=2020. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].|pdf=|usr=007}} | ||
+ | {{ttp|p=32498376|t=2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32486534|t=2020. [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].|pdf=|usr=007}} | ||
+ | {{tp|p=32433216|t=2020. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Corona virus.|pdf=|usr=007}} | ||
+ | {{ttp|p=32452762|t=2020. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.|pdf=|usr=007}} | ||
+ | {{tp|p=32507410|t=2020. The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.|pdf=|usr=007}} | ||
+ | {{tp|p=32508022|t=2020. Acute lung injury in patients with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32490934|t=2020. Ultrasound-guided minimally invasive autopsies: A protocol for the study of pulmonary and systemic involvement of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32443177|t=2020. Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy.|pdf=|usr=007}} | ||
+ | {{ttp|p=32441844|t=2020. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{ttp|p=32397951|t=2020. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets.|pdf=|usr=007}} | ||
+ | {{ttp|p=32420587|t=2020. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction.|pdf=|usr=007}} | ||
+ | {{ttp|p=32479682|t=2020. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study.|pdf=|usr=007}} | ||
+ | {{ttp|p=32497257|t=2020. A lesson from a saboteur: high molecular weight kininogen (HMWK) impact in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32488957|t=2020. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.|pdf=|usr=007}} | ||
+ | {{tp|p=32468052|t=2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.|pdf=|usr=007}} | ||
+ | {{ttp|p=32510973|t=2020. Decoding SARS-CoV-2 Hijacking of Host Mitochondria in Pathogenesis of COVID-19.|pdf=|usr=007}} | ||
+ | {{ttp|p=32497323|t=2020. Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection.|pdf=|usr=007}} | ||
+ | {{ttp|p=32469255|t=2020. SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism.|pdf=|usr=007}} | ||
+ | {{ttp|p=32492203|t=2020. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.|pdf=|usr=007}} | ||
+ | {{ttp|p=32434769|t=2020. Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19.|pdf=|usr=007}} | ||
+ | {{ttp|p=32501731|t=2020. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2?|pdf=|usr=007}} | ||
+ | {{tp|p=32506059|t=2020. Detection of Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Fluid of COVID-19 Patients: Is Perls Stain a Potential Indicator of Oxidative Alveolar Damage?|pdf=|usr=007}} | ||
+ | {{ttp|p=32496587|t=2020. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.|pdf=|usr=007}} | ||
+ | {{tp|p=32432483|t=2020. Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium.|pdf=|usr=007}} | ||
+ | {{tp|p=32437622|t=2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32472588|t=2020. Increased sFLT1/PlGF ratio in COVID-19: a novel link to Angiotensin II-mediated endothelial dysfunction.|pdf=|usr=007}} | ||
+ | {{tp|p=32491212|t=2020. Circulating endothelial cells in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32479159|t=2020. Related molecular mechanisms of COVID-19, hypertension, and diabetes.|pdf=|usr=007}} | ||
+ | {{tp|p=32510978|t=2020. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?|pdf=|usr=007}} | ||
+ | {{tp|p=32441303|t=2020. Placental Pathology in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32451533|t=2020. Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.|pdf=|usr=007}} | ||
+ | {{tp|p=32420938|t=2020. What happens to people's lungs when they get coronavirus disease 2019?|pdf=|usr=007}} | ||
+ | {{tp|p=32493030|t=2020. Thoughts on the alveolar phase of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32503680|t=2020. Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.|pdf=|usr=008}} | ||
+ | {{tp|p=32412156|t=2020. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.|pdf=|usr=008}} | ||
+ | {{tp|p=32379368|t=2020. Gastrointestinal effects of an attempt to "disinfect" from COVID-19.|pdf=|usr=008}} | ||
+ | {{ttp|p=32463221|t=2020. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients.|pdf=|usr=008}} | ||
+ | {{ttp|p=32444466|t=2020. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32422081|t=2020. Autopsy Report with Clinical Pathological Correlation.|pdf=|usr=007}} | ||
+ | {{tp|p=32525657|t=2020. Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia.|pdf=|usr=008}} | ||
+ | {{tp|p=32410724|t=2020. The Lungs before and after COVID-19 Pneumonia.|pdf=|usr=007}} | ||
+ | {{tp|p=32459123|t=2020. Mechanistic inferences from clinical reports of SARS-CoV-2.|pdf=|usr=008}} | ||
+ | {{tp|p=32406037|t=2020. COVID-19: is fibrosis the killer?|pdf=|usr=008}} | ||
+ | {{tp|p=32415560|t=2020. Bronchoalveolar lavage findings in severe COVID-19 pneumonia.|pdf=|usr=008}} | ||
+ | {{tp|p=32399954|t=2020. SARS-CoV-2 and myocardial injury: a role for Nox2?|pdf=|usr=008}} | ||
+ | {{tp|p=32494927|t=2020. Histological-ultrasonographical correlation of pulmonary involvement in severe COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32488341|t=2020. Rethinking the respiratory paradigm of COVID-19: a 'hole' in the argument.|pdf=|usr=008}} | ||
+ | {{tp|p=32533198|t=2020. Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32424481|t=2020. Stages or phenotypes? A critical look at COVID-19 pathophysiology.|pdf=|usr=008}} | ||
+ | {{tp|p=32424480|t=2020. Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 patient.|pdf=|usr=008}} | ||
+ | {{tp|p=32504146|t=2020. Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.|pdf=|usr=008}} | ||
+ | {{tp|p=32500199|t=2020. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.|pdf=|usr=008}} | ||
+ | {{tp|p=32458044|t=2020. Inside the lungs of COVID-19 disease.|pdf=|usr=008}} | ||
+ | {{tp|p=32451971|t=2020. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?|pdf=|usr=008}} | ||
+ | {{tp|p=32434770|t=2020. Predictive molecular pathology in the time of COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32497811|t=2020. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?|pdf=|usr=008}} | ||
+ | {{tp|p=32522846|t=2020. ACE2 and COVID-19 and the resulting ARDS.|pdf=|usr=008}} | ||
+ | {{tp|p=32473354|t=2020. Racial disparity in Covid-19 mortality rates - A plausible explanation.|pdf=|usr=008}} | ||
+ | {{tp|p=32479986|t=2020. Type 3 hypersensitivity in COVID-19 vasculitis.|pdf=|usr=008}} | ||
+ | {{tp|p=32437830|t=2020. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32462425|t=2020. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.|pdf=|usr=008}} | ||
+ | {{tp|p=32517773|t=2020. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32517769|t=2020. Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmark.|pdf=|usr=008}} | ||
+ | {{ttp|p=32432787|t=2020. SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy.|pdf=|usr=008}} | ||
+ | {{ttp|p=32474064|t=2020. A novel cell-based assay for dynamically detecting neutrophil extracellular traps-induced lung epithelial injuries.|pdf=|usr=008}} | ||
+ | {{ttp|p=32489244|t=2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.|pdf=|usr=008}} | ||
+ | {{ttp|p=32519786|t=2020. Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32399755|t=2020. A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32530583|t=2020. Neuropathological Features of Covid-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32427517|t=2020. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.|pdf=|usr=008}} | ||
+ | {{tp|p=32533838|t=2020. The pathological autopsy of coronavirus disease 2019 (COVID-2019) in China: a review.|pdf=|usr=008}} | ||
+ | {{ttp|p=32527928|t=2020. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32527925|t=2020. Type III interferons disrupt the lung epithelial barrier upon viral recognition.|pdf=|usr=008}} | ||
+ | {{ttp|p=32526773|t=2020. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32449057|t=2020. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.|pdf=|usr=008}} | ||
+ | {{tp|p=32513452|t=2020. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli.|pdf=|usr=008}} ''henoch schönlein like''' | ||
+ | {{tp|p=32425320|t=2020. Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32405074|t=2020. Visualization of SARS-CoV-2 virus invading the human placenta using electron microscopy.|pdf=|usr=008}} | ||
+ | {{tp|p=32387855|t=2020. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.|pdf=|usr=008}} | ||
+ | {{tp|p=32533928|t=2020. Letter-to-the-Editor: Alternative Interpretation to the Findings Reported in Visualization of SARS-CoV-2 Virus Invading the Human Placenta Using Electron Microscopy.|pdf=|usr=008}} | ||
+ | {{tp|p=32391518|t=2020. Detection of SARS-COV-2 in Placental and Fetal Membrane Samples.|pdf=|usr=008}} | ||
+ | {{tp|p=32427221|t=2020. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth.|pdf=|usr=008}} | ||
+ | {{tp|p=32471774|t=2020. SARS-CoV-2: Naso-bronchial cytological correlations.|pdf=|usr=008}} | ||
+ | {{tp|p=32436075|t=2020. Microvascular alterations in patients with SARS-COV-2 severe pneumonia.|pdf=|usr=008}} | ||
+ | {{tp|p=32419712|t=2020. COVID-19 and Dysfunctional Endothelium: The Mexican Scenario.|pdf=|usr=008}} | ||
+ | {{tp|p=32471702|t=2020. Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?|pdf=|usr=008}} | ||
+ | {{ttp|p=32485205|t=2020. The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.|pdf=|usr=008}} | ||
+ | {{tp|p=32407552|t=2020. Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.|pdf=|usr=008}} | ||
+ | {{tp|p=32512702|t=2020. COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.|pdf=|usr=008}} | ||
+ | {{ttp|p=32526206|t=2020. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.|pdf=|usr=008}} | ||
+ | {{ttp|p=32526273|t=2020. A plea for the pathogenic role of immune complexes in severe Covid-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32446945|t=2020. Do matrix metalloproteases mediate the SARS-CoV-2-related damage to the central nervous system?|pdf=|usr=008}} | ||
+ | {{tp|p=32447048|t=2020. SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples.|pdf=|usr=008}} | ||
+ | {{tp|p=32535877|t=2020. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).|pdf=|usr=008}} | ||
+ | {{tp|p=32533690|t=2020. Placental Pathology in COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32531085|t=2020. C1-INH and the contact system in COVID-19.|pdf=|usr=008}} | ||
+ | {{ttp|p=32579014|t=2020. Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19.|pdf=|usr=010}} | ||
+ | {{ttp|p=32563554|t=2020. Should we unstress SARS-CoV-2 infected cells?|pdf=|usr=011}} | ||
+ | {{tp|p=32526193|t=2020. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.|pdf=|usr=009}} | ||
+ | {{tp|p=32526191|t=2020. Pathologists in pursuit of the COVID-19 culprit.|pdf=|usr=009}} | ||
+ | {{tp|p=32386571|t=2020. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.|pdf=|usr=009}} | ||
+ | {{tp|p=32432896|t=2020. Respiratory Mechanics and Gas Exchange in COVID-19 Associated Respiratory Failure.|pdf=|usr=008}} | ||
+ | {{tp|p=32432895|t=2020. COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.|pdf=|usr=008}} | ||
+ | {{tp|p=32434816|t=2020. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?|pdf=|usr=008}} | ||
+ | {{tp|p=32386570|t=2020. Assessment of SARS-CoV-2 replication in the context of other respiratory viruses.|pdf=|usr=009}} | ||
+ | {{tp|p=32432897|t=2020. Reply: COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.|pdf=|usr=008}} | ||
+ | {{ttp|p=32579012|t=2020. COVID-19. Immunothrombosis and the gastrointestinal tract.|pdf=|usr=010}} | ||
+ | {{ttp|p=32454188|t=2020. Correlation between viral RNA shedding and serum antibodies in individuals with coronavirus disease 2019.|pdf=|usr=008}} | ||
+ | {{tp|p=32473124|t=2020. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.|pdf=|usr=009}} | ||
+ | {{tp|p=32430402|t=2020. Could severe COVID-19 be considered a complementopathy?|pdf=|usr=009}} | ||
+ | {{tp|p=32437497|t=2020. Postmortem Examination of Patients With COVID-19.|pdf=|usr=009}} | ||
+ | {{tp|p=32461141|t=2020. The case of Complement activation in COVID-19 multiorgan impact.|pdf=|usr=009}} | ||
+ | {{tp|p=32422178|t=2020. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.|pdf=|usr=009}} | ||
+ | {{tp|p=32422177|t=2020. Pulmonary fibrosis secondary to COVID-19: a call to arms?|pdf=|usr=009}} | ||
+ | {{tp|p=32525010|t=2020. Thrombotic microangiopathy in a patient with COVID-19.|pdf=|usr=009}} | ||
+ | {{ttp|p=32437765|t=2020. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect acute kidney injury and other organ injury in critically ill patients with COVID-19.|pdf=|usr=009}} | ||
+ | {{tp|p=32426558|t=2020. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy".|pdf=|usr=009}} | ||
+ | {{tp|p=32464112|t=2020. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?|pdf=|usr=009}} | ||
+ | {{tp|p=32504925|t=2020. What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?|pdf=|usr=009}} | ||
+ | {{tp|p=32534341|t=2020. Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths?|pdf=|usr=009}} | ||
+ | {{tp|p=32534340|t=2020. The intriguing commonality of NETosis between COVID-19 & Periodontal disease.|pdf=|usr=009}} | ||
+ | {{tp|p=32505073|t=2020. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression.|pdf=|usr=009}} | ||
+ | {{tp|p=32391393|t=2020. Digesting the crisis: autophagy and coronaviruses.|pdf=|usr=009}} | ||
+ | {{tp|p=32531352|t=2020. Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19.|pdf=|usr=009}} | ||
+ | {{ttp|p=32425647|t=2020. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency.|pdf=|usr=009}} | ||
+ | {{tp|p=32439870|t=2020. COVID-19: the vasculature unleashed.|pdf=|usr=009}} | ||
+ | {{ttp|p=32488201|t=2020. Blood clots and TAM receptor signalling in COVID-19 pathogenesis.|pdf=|usr=009}} | ||
+ | {{ttp|p=32425360|t=2020. Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases.|pdf=|usr=009}} | ||
+ | {{ttp|p=32532805|t=2020. Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.|pdf=|usr=009}} | ||
+ | {{tp|p=32519118|t=2020. Okulare Post-mortem-Befunde bei an COVID-19 verstorbenen Patienten.|pdf=|usr=009}} | ||
+ | {{ttp|p=32405877|t=2020. A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?|pdf=|usr=009}} | ||
+ | {{tp|p=32399393|t=2020. The potential role of TNFalpha in 2019 novel coronavirus pneumonia.|pdf=|usr=009}} | ||
+ | {{tp|p=32399806|t=2020. Is COVID-19 a New Hematologic Disease?|pdf=|usr=009}} | ||
+ | {{ttp|p=32505009|t=2020. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.|pdf=|usr=009}} | ||
+ | {{tp|p=32458383|t=2020. On barring the vascular gateway against severe COVID-19 disease.|pdf=|usr=008}} | ||
+ | {{tp|p=32589448|t=2020. Postmortem swabs in the Sars-CoV-2 Pandemic: Report on 12 complete clinical autopsy cases.|pdf=|usr=010}} | ||
+ | {{tp|p=32568751|t=2020. Abdominal Surgery in Patients with COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues.|pdf=|usr=010}} | ||
+ | {{tp|p=32579023|t=2020. Severe Hypoxemia in Early COVID-19 Pneumonia.|pdf=|usr=010}} | ||
+ | {{tp|p=32539537|t=2020. Why COVID-19 Silent Hypoxemia is Baffling to Physicians.|pdf=|usr=010}} | ||
+ | {{tp|p=32579380|t=2020. Adrenal Vascular Changes in COVID-19 Autopsies.|pdf=|usr=010}} | ||
+ | {{ttp|p=32543703|t=2020. SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure.|pdf=|usr=010}} | ||
+ | {{tp|p=32562764|t=2020. Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.|pdf=|usr=010}} | ||
+ | {{tp|p=32561682|t=2020. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype.|pdf=|usr=010}} | ||
+ | {{tp|p=32567404|t=2020. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2.|pdf=|usr=010}} | ||
+ | {{ttp|p=32554340|t=2020. The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives.|pdf=|usr=010}} | ||
+ | {{tp|p=32588493|t=2020. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.|pdf=|usr=010}} | ||
+ | {{tp|p=32541247|t=2020. Hypotension, SIRS and COVID-19: a clinical conundrum.|pdf=|usr=011}} | ||
+ | {{tp|p=32562746|t=2020. Tackle the free radicals damage in COVID-19.|pdf=|usr=010}} | ||
+ | {{tp|p=32610096|t=2020. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.|pdf=|usr=011}} | ||
+ | {{tp|p=32537959|t=2020. Reply: COVID-19, A and Hypersensitivity Pneumonitis.|pdf=|usr=011}} | ||
+ | {{ttp|p=32544615|t=2020. The role of extracellular vesicles in COVID-19 virus infection.|pdf=|usr=011}} | ||
+ | {{tp|p=32429235|t=2020. AMPK and the Need to Breathe and Feed: What's the Matter with Oxygen?|pdf=|usr=011}} | ||
+ | {{tp|p=32605192|t=2020. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review.|pdf=|usr=011}} | ||
+ | {{tp|p=32556101|t=2020. The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.|pdf=|usr=011}} | ||
+ | {{ttp|p=32549229|t=2020. Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes.|pdf=|usr=011}} | ||
+ | {{tp|p=32591314|t=2020. Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient.|pdf=|usr=011}} | ||
+ | {{tp|p=32585161|t=2020. Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis.|pdf=|usr=011}} | ||
+ | {{tp|p=32579991|t=2020. The lung tissue microbiota features of 20 deceased patients with COVID-19.|pdf=|usr=011}} | ||
+ | {{tp|p=32559309|t=2020. Hypermetabolism and COVID-19.|pdf=|usr=011}} | ||
+ | {{tp|p=32558957|t=2020. Subversion of host stress granules by coronaviruses: Potential roles of pi-rich disordered domains of viral nucleocapsids.|pdf=|usr=011}} | ||
+ | {{tp|p=32540605|t=2020. Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with (18)F-Fluorocholine PET/CT?|pdf=|usr=011}} | ||
+ | {{tp|p=32561129|t=2020. Perspective on oral exfoliative cytology and COVID-19.|pdf=|usr=011}} | ||
+ | {{tp|p=32547891|t=2020. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.|pdf=|usr=011}} | ||
+ | {{tp|p=32537129|t=2020. Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?|pdf=|usr=011}} | ||
+ | {{tp|p=32561706|t=2020. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.|pdf=|usr=011}} | ||
+ | {{tp|p=32580215|t=2020. Clinical course of COVID-19 pneumonia in a patient undergoing pneumonectomy and pathology findings during the incubation period.|pdf=|usr=011}} | ||
+ | {{tp|p=32595353|t=2020. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks.|pdf=|usr=011}} | ||
+ | {{tp|p=32539627|t=2020. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.|pdf=|usr=011}} | ||
+ | {{tp|p=32584242|t=2020. Lung Pathology in COVID-19 Disease: We Must Be Aware!|pdf=|usr=011}} | ||
+ | {{tp|p=32604146|t=2020. Reliable Postmortem Computed Tomography Scan Diagnosis of COVID-19 Pneumonia.|pdf=|usr=011}} | ||
+ | {{tp|p=32609531|t=2020. Radiology-pathology Correlation in Recovered COVID-19, Demonstrating Organizing Pneumonia.|pdf=|usr=011}} | ||
+ | {{tp|p=32581017|t=2020. Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.|pdf=|usr=011}} | ||
+ | {{tp|p=32597954|t=2020. Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome.|pdf=|usr=011}} | ||
+ | {{ttp|p=32568187|t=2020. COVID-19 and the endothelium.|pdf=|usr=011}} | ||
+ | {{ttp|p=32601125|t=2020. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis.|pdf=|usr=011}} | ||
+ | {{ttp|p=32563187|t=2020. Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation.|pdf=|usr=011}} | ||
+ | {{tp|p=32605920|t=2020. COVID-19 autopsy in people who died in community settings: the first series.|pdf=|usr=011}} | ||
+ | {{tp|p=32529795|t=2020. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.|pdf=|usr=011}} | ||
+ | {{tp|p=32574283|t=2020. Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics.|pdf=|usr=011}} | ||
+ | {{ttp|p=32595654|t=2020. Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.|pdf=|usr=011}} | ||
+ | {{tp|p=32582222|t=2020. The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?|pdf=|usr=011}} | ||
+ | {{tp|p=32581816|t=2020. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19.|pdf=|usr=011}} | ||
+ | {{tp|p=32606379|t=2020. The network effect: studying COVID-19 pathology with the Human Cell Atlas.|pdf=|usr=011}} | ||
+ | {{ttp|p=32608159|t=2020. COVID-19: a collision of complement, coagulation and inflammatory pathways.|pdf=|usr=011}} | ||
+ | {{tp|p=32607467|t=2020. Pathological Role of Angiotensin II in Severe COVID-19.|pdf=|usr=011}} | ||
+ | {{tp|p=32607684|t=2020. The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation.|pdf=|usr=011}} | ||
+ | {{tp|p=32597823|t=2020. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" Translational review and therapeutic perspectives.|pdf=|usr=011}} | ||
+ | {{tp|p=32499417|t=2020. Blood vessel injury may spur disease's fatal second phase.|pdf=|usr=011}} | ||
+ | {{tp|p=32747912|t=2020. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.|pdf=|usr=017}} | ||
+ | {{tp|p=32719039|t=2020. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.|pdf=|usr=018}} | ||
+ | {{ttp|p=32707276|t=2020. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19.|pdf=|usr=017}} | ||
+ | {{tp|p=C7238751|t=?. Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections.|pdf=|usr=015}} | ||
+ | {{tp|p=32612961|t=2020. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.|pdf=|usr=015}} | ||
+ | {{tp|p=32734876|t=2020. [Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].|pdf=|usr=017}} | ||
+ | {{tp|p=32755116|t=2020. COVID-19 infeksiyonunun otopsi ve biyopsi raporlarina gore patolojik ozellikleri.|pdf=|usr=017}} | ||
+ | {{tp|p=32719039|t=2020. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.|pdf=|usr=017}} | ||
+ | {{tp|p=C7313767|t=?. Autopsy of COVID-19 victims in China.|pdf=|usr=015}} | ||
+ | {{ttp|p=32612974|t=2020. COVID-19 Is Further Subdivided Into COVIP-19 and COVII-19.|pdf=|usr=015}} | ||
+ | *[https://www.xcdsystem.com/uscap/program/eJ02pRV/index.cfm?pgid=3833 webinar on pulmonary pathology uscap] | ||
+ | {{ttp|p=32643596|t=2020. A review on histotechnology practices in COVID-19 pathology investigations.|pdf=|usr=012}} | ||
+ | {{ttp|p=32707276|t=2020. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19.|pdf=|usr=017}} | ||
+ | {{tp|p=32747912|t=2020. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.|pdf=|usr=017}} | ||
+ | {{tp|p=32734876|t=2020. [Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].|pdf=|usr=017}} | ||
+ | {{tp|p=32739876|t=2020. Autopsies of COVID-19 deceased? Absolutely!|pdf=|usr=017}} | ||
+ | {{tp|p=32755116|t=2020. COVID-19 infeksiyonunun otopsi ve biyopsi raporlarina gore patolojik ozellikleri.|pdf=|usr=017}} | ||
+ | {{tp|p=C7238751|t=?. Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections.|pdf=|usr=015}} | ||
+ | *[https://www.xcdsystem.com/uscap/program/eJ02pRV/index.cfm?pgid=3833 webinar on pulmonary pathology uscap] | ||
+ | {{tp|p=C7313767|t=?. Autopsy of COVID-19 victims in China.|pdf=|usr=015}} | ||
+ | |||
+ | |||
+ | ===host genetics=== | ||
+ | see also here... [[Diagnosis_(Laboratory_other_parameters)]] |
Aktuelle Version vom 30. September 2020, 11:02 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
I further streaming-in related content is here
32273135 ä. Analysis of Characteristics in Death Patients with COVID-19 Pneumonia without Underlying Diseases
32275742 ä. COVID-19 Autopsies, Oklahoma, USA
32361635 2020. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients
32163542 ä. Histopathologic Changes and SARS?CoV-2 Immunostaining in the Lung of a Patient With COVID-19
32360606 2020. SARS-CoV2 entry and spread in the lymphatic drainage system of the brain
32353523 ä. SARS-CoV-2: a new virus but a familiar inflammation brain pattern
32370257 2020. Bioenergy Crisis in Coronavirus Diseases?
32375085 ä. Pathophysiological Characteristics and Therapeutic Approaches for Pulmonary Injury and Cardiovascular Complications of Coronavirus Disease 2019
32346074 ä. Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient
32360729 ä. Postmortem Lung Findings in an Asthmatic with Coronavirus Disease 2019 (COVID-19)
32283063 ä. A call to action : the need for autopsies to determine the full extent of organ involvement associated with COVID-19 infections
32334082 ä. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
32270184 ä. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
32307550 ä. Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients
32207983 2020. Covid-19 infection and mortality: a physiologist?s perspective enlightening clinical features and plausible interventional strategies
32234451 ä. COVID-19, SARS and MERS: are they closely related?
32575076 2020. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response.
32294179 ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
32293672 ä. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
32350105 ä. Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection
32341103 2020. Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review
32198987 2020. Gross examination report of a COVID-19 death autopsy
32198986 2020. Review and Prospect of Pathological Features of Corona Virus Disease
32198985 2020. Guide to the Forensic Pathology Practice on Death Cases Related to Corona Virus Disease 2019 COVID-19 Trial Draft
32198984 2020. Academician Cong Bin: Autopsy of SARS-CoV-2 infection is needed to be strengthened
32198983 2020. From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy
32170560 ä. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
32551862 2020. NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19.
32317509 2020. COVID-19 and lung pathology
32345362 2020. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
32333601 ä. Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
32586680 2020. A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients.
32094336 2020. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
32283245 ä. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
32282428 ä. What s Old is New! Similarities Between SARS-CoV-2 and HIV
32303424 ä. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19
32315733 ä. Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms
32583086 2020. COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. |
32357503 2020. COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!
32244779 2020. Master Regulator Analysis of the SARS-CoV-2/Human Interactome
32366599 2020. SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma
32565512 2020. Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China.
32283163 ä. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2
32348495 ä. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19
32344401 2020. COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes
32080991 2020. Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea
32056249 2020. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS?CoV, MERS?CoV, and 2019?nCoV
32539769 2020. COVID-19 targets the right lung.
32340678 2020. Pathology of 2019 Novel Coronavirus Pneumonia: A Dynamic Disease Process
32194247 ä. Exuberant Plasmocytosis in Bronchoalveolar Lavage Specimen of the First Patient Requiring Extracorporeal Membrane Oxygenation for SARS-CoV-2 in Europe
32114094 ä. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
32558055 2020. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection.
32379723 2020. Molecular detection of SARS-CoV-2 in formalin fixed paraffin embedded specimens
32329756 2020. Neutrophil extracellular traps in COVID-19 |
32574956 2020. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. |
32368701 ä. COVID-19?Associated Collapsing Glomerulopathy: An Emerging Entity
32327202 ä. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
C7142700 ä. Collapsing Glomerulopathy in a Patient With Coronavirus Disease 2019 (COVID-19)
32346659 ä. Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection
32311318 ä. SARS-CoV-2 and viral sepsis: observations and hypotheses
32325026 2020. Endothelial cell infection and endotheliitis in COVID-19
32559338 2020. Autopsy registry can facilitate COVID-19 research.
32199493 ä. Viral dynamics in mild and severe cases of COVID-19
32330440 ä. Mediastinal lymphadenopathy in patients with severe COVID-19
32105638 ä. Viral load of SARS-CoV-2 in clinical samples
32085846 ä. Pathological findings of COVID-19 associated with acute respiratory distress syndrome
32341791 2020. Thoughts on COVID-19 and autoimmune diseases
32344305 ä. A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: potential implications for the SARS-CoV-2 modus operandi
32583353 2020. What about COVID-19 and arachidonic acid pathway?
32243911 ä. C-reactive protein levels in the early stage of COVID-19
32291399 ä. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
32249846 ä. Dysregulation of lung myeloid cells in COVID-19
32554538 2020. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? |
32216698 2020. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
32297540 2020. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study
32348339 2020. Correlation between Heart fatty acid binding protein and severe COVID-19: A case-control study
32298273 2020. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study
32542743 2020. Diffuse Alveolar Damage (DAD) from Coronavirus Disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.
32326988 ä. Lactose Dehydrogenase in Patients with Severe COVID-19: A Meta-Analysis of Retrospective Study
32339247 ä. Does apolipoprotein E genotype predict COVID-19 severity?
32371949 2020. Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study
32360977 ä. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research? |
32305740 ä. Severe COVID-19 infection associated with endothelial activation |
32299776 ä. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases |
32283217 ä. Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings
32356025 ä. Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen
32350596 ä. The autopsy debate during the COVID-19 emergency: the Italian experience
32552178 2020. Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients.
32379417 ä. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age
32376402 ä. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies |
32361194 ä. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons |
32323565 2020. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19? |
32379894 2020. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia
32259373 2020. Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An Italian institutional experience focusing on biosafety procedures
32346073 2020. COVID-19: towards understanding of pathogenesis
32557383 2020. Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients. |
32294809 2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
32246845 2020. SARS?CoV?2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells
32353898 2020. Histopathology and genetic susceptibility in COVID-19 pneumonia
32367579 2020. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications
32559180 2020. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.
32364407 2020. COVID-19 Lung Injury Is Different From High Altitude Pulmonary Edema (Re: High Alt Med Biol Epub ahead of print ; DOI: 10 1089/ham 2020 0055)
32281877 2020. COVID-19 Lung Injury is Not High Altitude Pulmonary Edema
32374419 2020. Pulmonary Pathology of Early Phase COVID-19 Pneumonia in a Patient with a Benign Lung Lesion
32364264 2020. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction |
32371536 2020. Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2 |
32198191 2020. Autopsy in suspected COVID-19 cases
32358895 2020. Histological pattern in Covid-19 induced viral rash
32554923 2020. The complement system in COVID-19: friend and foe?
32369204 2020. Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications
32294295 2020. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19
32376101 ä. Association Between Hypoxemia and Mortality in Patients With COVID-19 |
32272081 2020. Understanding pathways to death in patients with COVID-19 |
32327758 2020. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
32572155 2020. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.
32576678 2020. Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.
32592919 2020. Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): Gender and age influences.
32570168 2020. Microvascular disease confers additional risk to COVID-19 infection.
32273618 2020. How does COVID-19 kill? Uncertainty is hampering doctors ability to choose treatments
32371892 2020. COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms |
32339089 2020. Issues on Coronavirus Disease 2019 (COVID-19) Pathogenesis
32172546 2020. A pathological report of three COVID-19 cases by minimal invasive autopsies
32171194 2020. Pathological changes with novel coronavirus infection in lung cancer surgical specimen
32153166 2020. Provisional guidelines on autopsy practice for deaths associated with COVID-19
32268662 2020. Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy
32157847 2020. How to understand the histopathology of SARS and coronavirus disease-19 (COVID-19) associated with acute respiratory distress syndrome
32084674 2020. Detection of 2019-nCoV in the pathological paraffin embedded tissue
32340089 2020. Pathological changes of the spleen in ten patients with new coronavirus infection by minimally invasive autopsies
32114744 2020. Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases
32174095 2020. Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures
32561849 2020. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19.
C7173822 2020. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study
32379077 2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS
32434133 2020. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities
32314313 ä. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
32427582 2020. Clinical and pathological investigation of severe COVID-19 patients.
32512569 2020. COVID-19 Attacks the Kidney: Ultrastructural Evidence for the Presence of Virus in the Glomerular Epithelium. |
32403217 2020. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. |
32272221 ä. Host proteases as determinants of coronaviral neurotropism and virulence
32243808 2020. The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future |
32375845 2020. Acute respiratory failure in COVID-19: is it ?typical? ARDS?
32439197 ä. COVID-19 and Multiorgan Response
32362921 2020. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies
32340677 2020. Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia
32471641 ä. Tubuloreticular inclusions in COVID-19?related collapsing glomerulopathy
32471639 ä. Collapsing glomerulopathy in a COVID-19 patient
32292867 2020. Collapsing Glomerulopathy in a Patient With COVID-19
32459663 2020. COVID-19, microangiopathy, hemostatic activation, and complement.
32242089 ä. Endocrine and metabolic link to coronavirus infection
32382135 ä. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis
C7158196 2009. 64pp on topic review (+) Molecular Basis of Pulmonary Disease
C7197563 ä. Plasma Metabolomic and Lipidomic Alterations Associated with COVID-19
32454497 2020. COVID-19 and Nasal Cytobrush Cytology.
32437316 2020. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States.
32412897 2020. Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.
32484232 2020. Radiologisk och histologisk bild for en okad forstaelse vid covid-19.
32512290 2020. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
32401000 2020. First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem. |
32397896 2020. Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings.
32436629 2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis. |
32421281 2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4? |
32485101 2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
32423917 2020. COVID-19 as an Acute Inflammatory Disease.
32469258 2020. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.
32437597 2020. Covid-19, Angiogenesis, and ARDS Endotypes. |
32437596 2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. |
32213267 2020. [Interpretation of pathological changes for "Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Version 7) "].
32490726 2020. Thromboinflammatory response in SARS-CoV-2 sepsis. |
32348061 2020. COVID-19, une maladie endotheliale ? |
32455515 2020. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].
32498376 2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19. |
32486534 2020. [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].
32433216 2020. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Corona virus.
32452762 2020. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. |
32507410 2020. The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.
32508022 2020. Acute lung injury in patients with COVID-19 infection.
32490934 2020. Ultrasound-guided minimally invasive autopsies: A protocol for the study of pulmonary and systemic involvement of COVID-19.
32443177 2020. Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy.
32441844 2020. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2. |
32397951 2020. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets. |
32420587 2020. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. |
32479682 2020. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study. |
32497257 2020. A lesson from a saboteur: high molecular weight kininogen (HMWK) impact in COVID-19. |
32488957 2020. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
32468052 2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.
32510973 2020. Decoding SARS-CoV-2 Hijacking of Host Mitochondria in Pathogenesis of COVID-19. |
32497323 2020. Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection. |
32469255 2020. SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism. |
32492203 2020. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer. |
32434769 2020. Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19. |
32501731 2020. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2? |
32506059 2020. Detection of Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Fluid of COVID-19 Patients: Is Perls Stain a Potential Indicator of Oxidative Alveolar Damage?
32496587 2020. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. |
32432483 2020. Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium.
32437622 2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.
32472588 2020. Increased sFLT1/PlGF ratio in COVID-19: a novel link to Angiotensin II-mediated endothelial dysfunction.
32491212 2020. Circulating endothelial cells in COVID-19.
32479159 2020. Related molecular mechanisms of COVID-19, hypertension, and diabetes.
32510978 2020. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?
32441303 2020. Placental Pathology in COVID-19.
32451533 2020. Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.
32420938 2020. What happens to people's lungs when they get coronavirus disease 2019?
32493030 2020. Thoughts on the alveolar phase of COVID-19.
32503680 2020. Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.
32412156 2020. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.
32379368 2020. Gastrointestinal effects of an attempt to "disinfect" from COVID-19.
32463221 2020. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. |
32444466 2020. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2. |
32422081 2020. Autopsy Report with Clinical Pathological Correlation.
32525657 2020. Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia.
32410724 2020. The Lungs before and after COVID-19 Pneumonia.
32459123 2020. Mechanistic inferences from clinical reports of SARS-CoV-2.
32406037 2020. COVID-19: is fibrosis the killer?
32415560 2020. Bronchoalveolar lavage findings in severe COVID-19 pneumonia.
32399954 2020. SARS-CoV-2 and myocardial injury: a role for Nox2?
32494927 2020. Histological-ultrasonographical correlation of pulmonary involvement in severe COVID-19.
32488341 2020. Rethinking the respiratory paradigm of COVID-19: a 'hole' in the argument.
32533198 2020. Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection.
32424481 2020. Stages or phenotypes? A critical look at COVID-19 pathophysiology.
32424480 2020. Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 patient.
32504146 2020. Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.
32500199 2020. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.
32458044 2020. Inside the lungs of COVID-19 disease.
32451971 2020. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?
32434770 2020. Predictive molecular pathology in the time of COVID-19.
32497811 2020. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
32522846 2020. ACE2 and COVID-19 and the resulting ARDS.
32473354 2020. Racial disparity in Covid-19 mortality rates - A plausible explanation.
32479986 2020. Type 3 hypersensitivity in COVID-19 vasculitis.
32437830 2020. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
32462425 2020. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
32517773 2020. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19.
32517769 2020. Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmark.
32432787 2020. SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy. |
32474064 2020. A novel cell-based assay for dynamically detecting neutrophil extracellular traps-induced lung epithelial injuries. |
32489244 2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings. |
32519786 2020. Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection. |
32399755 2020. A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19.
32530583 2020. Neuropathological Features of Covid-19.
32427517 2020. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.
32533838 2020. The pathological autopsy of coronavirus disease 2019 (COVID-2019) in China: a review.
32527928 2020. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. |
32527925 2020. Type III interferons disrupt the lung epithelial barrier upon viral recognition.
32526773 2020. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection. |
32449057 2020. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.
32513452 2020. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli.' henoch schönlein like
32425320 2020. Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.
32405074 2020. Visualization of SARS-CoV-2 virus invading the human placenta using electron microscopy.
32387855 2020. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.
32533928 2020. Letter-to-the-Editor: Alternative Interpretation to the Findings Reported in Visualization of SARS-CoV-2 Virus Invading the Human Placenta Using Electron Microscopy.
32391518 2020. Detection of SARS-COV-2 in Placental and Fetal Membrane Samples.
32427221 2020. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth.
32471774 2020. SARS-CoV-2: Naso-bronchial cytological correlations.
32436075 2020. Microvascular alterations in patients with SARS-COV-2 severe pneumonia.
32419712 2020. COVID-19 and Dysfunctional Endothelium: The Mexican Scenario.
32471702 2020. Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?
32485205 2020. The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway. |
32407552 2020. Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.
32512702 2020. COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.
32526206 2020. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract. |
32526273 2020. A plea for the pathogenic role of immune complexes in severe Covid-19. |
32446945 2020. Do matrix metalloproteases mediate the SARS-CoV-2-related damage to the central nervous system?
32447048 2020. SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples.
32535877 2020. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).
32533690 2020. Placental Pathology in COVID-19.
32531085 2020. C1-INH and the contact system in COVID-19.
32579014 2020. Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19. |
32563554 2020. Should we unstress SARS-CoV-2 infected cells? |
32526193 2020. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
32526191 2020. Pathologists in pursuit of the COVID-19 culprit.
32386571 2020. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
32432896 2020. Respiratory Mechanics and Gas Exchange in COVID-19 Associated Respiratory Failure.
32432895 2020. COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.
32434816 2020. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?
32386570 2020. Assessment of SARS-CoV-2 replication in the context of other respiratory viruses.
32432897 2020. Reply: COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.
32579012 2020. COVID-19. Immunothrombosis and the gastrointestinal tract. |
32454188 2020. Correlation between viral RNA shedding and serum antibodies in individuals with coronavirus disease 2019. |
32473124 2020. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.
32430402 2020. Could severe COVID-19 be considered a complementopathy?
32437497 2020. Postmortem Examination of Patients With COVID-19.
32461141 2020. The case of Complement activation in COVID-19 multiorgan impact.
32422178 2020. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
32422177 2020. Pulmonary fibrosis secondary to COVID-19: a call to arms?
32525010 2020. Thrombotic microangiopathy in a patient with COVID-19.
32437765 2020. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect acute kidney injury and other organ injury in critically ill patients with COVID-19. |
32426558 2020. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy".
32464112 2020. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
32504925 2020. What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
32534341 2020. Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths?
32534340 2020. The intriguing commonality of NETosis between COVID-19 & Periodontal disease.
32505073 2020. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression.
32391393 2020. Digesting the crisis: autophagy and coronaviruses.
32531352 2020. Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19.
32425647 2020. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. |
32439870 2020. COVID-19: the vasculature unleashed.
32488201 2020. Blood clots and TAM receptor signalling in COVID-19 pathogenesis. |
32425360 2020. Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases. |
32532805 2020. Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase. |
32519118 2020. Okulare Post-mortem-Befunde bei an COVID-19 verstorbenen Patienten.
32405877 2020. A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19? |
32399393 2020. The potential role of TNFalpha in 2019 novel coronavirus pneumonia.
32399806 2020. Is COVID-19 a New Hematologic Disease?
32505009 2020. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients. |
32458383 2020. On barring the vascular gateway against severe COVID-19 disease.
32589448 2020. Postmortem swabs in the Sars-CoV-2 Pandemic: Report on 12 complete clinical autopsy cases.
32568751 2020. Abdominal Surgery in Patients with COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues.
32579023 2020. Severe Hypoxemia in Early COVID-19 Pneumonia.
32539537 2020. Why COVID-19 Silent Hypoxemia is Baffling to Physicians.
32579380 2020. Adrenal Vascular Changes in COVID-19 Autopsies.
32543703 2020. SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure. |
32562764 2020. Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.
32561682 2020. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype.
32567404 2020. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2.
32554340 2020. The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives. |
32588493 2020. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.
32541247 2020. Hypotension, SIRS and COVID-19: a clinical conundrum.
32562746 2020. Tackle the free radicals damage in COVID-19.
32610096 2020. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis.
32537959 2020. Reply: COVID-19, A and Hypersensitivity Pneumonitis.
32544615 2020. The role of extracellular vesicles in COVID-19 virus infection. |
32429235 2020. AMPK and the Need to Breathe and Feed: What's the Matter with Oxygen?
32605192 2020. Clinical-Forensic Autopsy Findings to Defeat COVID-19 Disease: A Literature Review.
32556101 2020. The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
32549229 2020. Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes. |
32591314 2020. Collapsing glomerulopathy associated with COVID-19 infection in a heart transplant recipient.
32585161 2020. Hepatocellular Type II Fibrinogen Inclusions in a Patient with Severe COVID-19 and Hepatitis.
32579991 2020. The lung tissue microbiota features of 20 deceased patients with COVID-19.
32559309 2020. Hypermetabolism and COVID-19.
32558957 2020. Subversion of host stress granules by coronaviruses: Potential roles of pi-rich disordered domains of viral nucleocapsids.
32540605 2020. Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with (18)F-Fluorocholine PET/CT?
32561129 2020. Perspective on oral exfoliative cytology and COVID-19.
32547891 2020. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.
32537129 2020. Rethinking COVID-19 'pneumonia' - is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?
32561706 2020. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
32580215 2020. Clinical course of COVID-19 pneumonia in a patient undergoing pneumonectomy and pathology findings during the incubation period.
32595353 2020. Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks.
32539627 2020. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.
32584242 2020. Lung Pathology in COVID-19 Disease: We Must Be Aware!
32604146 2020. Reliable Postmortem Computed Tomography Scan Diagnosis of COVID-19 Pneumonia.
32609531 2020. Radiology-pathology Correlation in Recovered COVID-19, Demonstrating Organizing Pneumonia.
32581017 2020. Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.
32597954 2020. Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome.
32568187 2020. COVID-19 and the endothelium. |
32601125 2020. Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis. |
32563187 2020. Attenuated interferon and pro-inflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. |
32605920 2020. COVID-19 autopsy in people who died in community settings: the first series.
32529795 2020. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies.
32574283 2020. Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics.
32595654 2020. Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells. |
32582222 2020. The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
32581816 2020. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19.
32606379 2020. The network effect: studying COVID-19 pathology with the Human Cell Atlas.
32608159 2020. COVID-19: a collision of complement, coagulation and inflammatory pathways. |
32607467 2020. Pathological Role of Angiotensin II in Severe COVID-19.
32607684 2020. The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation.
32597823 2020. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" Translational review and therapeutic perspectives.
32499417 2020. Blood vessel injury may spur disease's fatal second phase.
32747912 2020. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.
32719039 2020. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.
32707276 2020. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19. |
C7238751 ?. Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections.
32612961 2020. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
32734876 2020. [Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].
32755116 2020. COVID-19 infeksiyonunun otopsi ve biyopsi raporlarina gore patolojik ozellikleri.
32719039 2020. Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences.
C7313767 ?. Autopsy of COVID-19 victims in China.
32612974 2020. COVID-19 Is Further Subdivided Into COVIP-19 and COVII-19. |
32643596 2020. A review on histotechnology practices in COVID-19 pathology investigations. |
32707276 2020. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19. |
32747912 2020. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.
32734876 2020. [Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].
32739876 2020. Autopsies of COVID-19 deceased? Absolutely!
32755116 2020. COVID-19 infeksiyonunun otopsi ve biyopsi raporlarina gore patolojik ozellikleri.
C7238751 ?. Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections.
C7313767 ?. Autopsy of COVID-19 victims in China.
host genetics
see also here... Diagnosis_(Laboratory_other_parameters)